Skip to content

UCB SA Price, Chart & Factor Exposure

Free Data & Analytics Access

Next earnings: Thu, Feb 25, 2027, after the market closes · estimates and history

UCB SA · E.UCB.BR · Belgium
Use symbol E.UCB.BR in our API & Excel add-in to retrieve this data ↓
279.60
(-0.01%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 50%
Trend 75%
Bubble Risk LOW
Realised Volatility (20D) 25.96%

UCB SA Forecast

UCB SA short-term momentum is positive (up over 3 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (7 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 26.0% a year, a typical one-standard-deviation range is 269.38–289.82 over a week, 258.65–300.55 over a month and 207.02–352.18 over a year. (Signals as of 21 Nov 2026.)

UCB SA Price Chart

MacroFinance.ai
Market/MacroIndicatorNowChangeRange
Quantitative
UCB SA
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
UCB SA
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
UCB SA
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
UCB SA
P/E
15.07x
Mid-range vs own history
QoQ +26.1%
YoY −47.7%
now 15.066110.97 low30.58 high
ⓘP/E As of 22 Nov 2026.See UCB SA returns when P/E looked like now →Opens Return analysis with the filter P/E within ±5% of today
UCB SA
P/S
3.46x
Mid-range vs own history
QoQ +26.1%
YoY −6.1%
now 3.45582.52 low3.91 high
ⓘP/S As of 22 Nov 2026.See UCB SA returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
UCB SA
P/B
4.56x
Stretched vs own history
QoQ +26.1%
YoY −2.5%
now 4.55843.32 low4.97 high
ⓘP/B As of 22 Nov 2026.See UCB SA returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
UCB SA
EV/EBITDA
11.59x
Mid-range vs own history
QoQ +24.5%
YoY −11.8%
now 11.5868.59 low13.97 high
ⓘEV/EBITDA As of 22 Nov 2026.See UCB SA returns when EV/EBITDA looked like now →Opens Return analysis with the filter EV/EBITDA within ±5% of today
UCB SA
EV/Sales
3.64x
Mid-range vs own history
QoQ +24.5%
YoY −3.8%
now 3.63742.7 low4.01 high
ⓘEV/Sales As of 22 Nov 2026.See UCB SA returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
UCB SA
FCF Yield
5.1%
Mid-range vs own history
QoQ −20.7%
YoY +28.7%
now 5.12213.75 low7.04 high
ⓘFCF Yield As of 22 Nov 2026.See UCB SA returns when FCF Yield looked like now →Opens Return analysis with the filter FCF Yield within ±5% of today
UCB SA
Earnings Yield
6.6%
Mid-range vs own history
QoQ −20.7%
YoY +91.1%
now 6.63743.27 low9.12 high
ⓘEarnings Yield As of 22 Nov 2026.See UCB SA returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
UCB SA
Market Cap
$53.1B
Highest in 5 years
QoQ +26.1%
YoY +17.4%
now 53123.161238,664 low56,334 high
ⓘMarket Cap As of 22 Nov 2026.See UCB SA returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
UCB SA
Net Debt
$2.8B
High vs own history
QoQ 0.0%
YoY +120.3%
now 2791-225 low2,791 high
ⓘNet Debt As of 22 Nov 2026.See UCB SA returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
UCB SA
Net Debt / EBITDA
0.58x
0.58x
QoQ 0.0%
YoY +61.6%
now 0.5783-0.06 low0.58 high
ⓘNet Debt / EBITDA As of 22 Nov 2026.See UCB SA returns when Net Debt / EBITDA looked like now →Opens Return analysis with the filter Net Debt / EBITDA within ±5% of today
UCB SA
Current Ratio
1.20x
Mid-range vs own history
QoQ 0.0%
YoY −11.1%
now 1.20341.2 low1.38 high
ⓘCurrent Ratio As of 22 Nov 2026.See UCB SA returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
UCB SA
Quick Ratio
0.82x
Mid-range vs own history
QoQ 0.0%
YoY −18.6%
now 0.81990.82 low1.04 high
ⓘQuick Ratio As of 22 Nov 2026.See UCB SA returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
UCB SA
Interest Coverage
8.12x
8.12x
QoQ 0.0%
YoY +73.8%
now 8.11854.67 low8.12 high
ⓘInterest Coverage As of 22 Nov 2026.See UCB SA returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
UCB SA
Debt / Equity
0.31x
Mid-range vs own history
QoQ 0.0%
YoY +3.6%
now 0.30790.21 low0.31 high
ⓘDebt / Equity As of 22 Nov 2026.See UCB SA returns when Debt / Equity looked like now →Opens Return analysis with the filter Debt / Equity within ±5% of today
UCB SA
Piotroski F-Score
5
5
QoQ 0.0%
YoY −16.7%
now 55 low6 high
ⓘPiotroski F-Score As of 22 Nov 2026.See UCB SA returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
UCB SA
Altman Z-Score
5.55
Mid-range vs own history
QoQ +15.3%
YoY +1.4%
now 5.54864.58 low6.37 high
ⓘAltman Z-Score As of 22 Nov 2026.See UCB SA returns when Altman Z-Score looked like now →Opens Return analysis with the filter Altman Z-Score within ±5% of today
  12 members-only factors: Estimate Revision 30D, Forward P/E, Gross Margin, EBITDA Margin and moreSign up
Accounting Red Flags
  17 members-only factors: Sloan Accruals, Cash-Earnings Gap, Beneish M-Score, Days Sales in Receivables Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for UCB SA, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

UCB SA fundamentals: income statement, balance sheet & cash flow

UCB SA reported revenue of €7.74bn and net income of €1.56bn in FY2025, the year ended 31 December 2025 — revenue up 25.8% and net income up 46.3% on the prior year. Free cash flow was €1.88bn. These figures are as reported in the filings, not restated: 26 fiscal years and 93 quarters of history, back to December 2000.

Revenue (FY2025)
€7.74bn
+25.8%
Net income
€1.56bn
+46.3%
Gross margin
71.14%
Free cash flow
€1.88bn
+104.6%
Net debt
-€6.0m
UCB SA income statement, annual, as reported · EUR millions unless stated
EUR millionsFY2025FY2024FY2023FY2022FY2021
Period end31 Dec 202531 Dec 202431 Dec 202331 Dec 202231 Dec 2021
Revenue7,741.06,152.05,252.05,517.05,777.0
Cost of revenue2,234.01,752.01,707.01,863.01,612.0
Gross profit5,507.04,400.03,545.03,654.04,165.0
Research & development1,822.01,781.01,630.01,670.01,629.0
Selling, general & admin.2,519.01,295.01,311.01,584.01,389.0
Operating income1,166.01,324.0604.0400.01,147.0
EBITDA1,793.01,963.01,276.01,167.01,594.0
Interest expense128.0159.0144.071.045.0
Pre-tax income1,822.01,163.0441.0511.01,226.0
Income tax264.098.098.091.0170.0
Net income1,558.01,065.0343.0418.01,058.0

Download UCB SA fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.UCB.BR&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks all 26 fiscal years and 93 quarters, the filing vintages behind each number and API access.
Create free account

Figures in EUR, statements as filed. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic.

Research on UCB SA

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

UCB SA Trading Strategies

9 backtested tactical asset allocation strategies hold VGK (European market), the closest tradable exposure to UCB SA; 1 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

Explore all strategies →

Statistical Distribution of Returns

Plus

How UCB SA’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how UCB SA behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About UCB SA (Belgium)

UCB SA is a listed security in Belgium. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

More on UCB SA

Frequently asked questions

What is UCB SA?
UCB SA is a listed security in Belgium. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest UCB SA price?
The latest close is 279.6 (21 Nov 2026), -0.01% on the day. The price at the top of the page refreshes during the trading day.
Is UCB SA in an uptrend?
As of 21 Nov 2026, short-term momentum is positive (3 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly positive (7 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is UCB SA?
20-day realised volatility is 26.0% a year (21 Nov 2026), which implies a typical one-standard-deviation move of about 7.5% over a month and 3.7% over a week.
What factors affect UCB SA?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to UCB SA, grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade UCB SA?
9 backtested tactical asset allocation strategies trade UCB SA through VGK; 1 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are UCB SA returns analysed?
The Statistical Distribution of Returns section shows the distribution of UCB SA daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free UCB SA historical data?
In the Free historical data section of this page: the last 10 years of UCB SA daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free UCB SA historical data (last 10 years)

Browse or instantly download the last 10 years of UCB SA daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.UCB.BR&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-20279.6
2026-11-19283.2
2026-11-18285.1
2026-11-17286.8
2026-11-16295.1
2026-11-13296.5
2026-11-12295.2
2026-11-11291.3
2026-11-10294.5
2026-11-09298.8
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company offers Cimzia for ankylosing spondylitis (AS), axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, polyarticular juvenile idiopathic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; and Neupro for Parkinson's disease and restless legs syndrome. It also provides Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies. In addition, the company offers Evenity for the treatment of osteoporosis in postmenopausal women; Bimzelx to treat plaque psoriasis, psoriatic arthritis, hidradenitis suppurativa, and axial spondyloarthritis; Fintepla for the treatment of Dravet and Lennox-Gastaut syndrome; and RYSTIGGO and ZILBRYSQ to treat people living with generalized myasthenia gravis. Further, it develops KYGEVVI (doxecitine/doxribtimine) for thymidine kinase 2 deficiency disorder; fenfluramine to treat CDKL5 deficiency disorder, and RETT-Syndrome; dapirolizumab pegol for systemic lupus erythematosus; STACCATO alprazolam for treating stereotypical prolonged seizures; bepranemab to treat Alzheimer's disease; and UCB9741 for atopic dermatitis, non cystic fibrosis bronchiectasis, and chronic obstructive pulmonary disease. Additionally, it engages in the contract manufacturing activities. The company was incorporated in 1925 and is headquartered in Brussels, Belgium.